Switching between A-rated anti-epileptic drug formulations does not increase seizure risk

Links shared publicly online about this topic.

1,524
total visits

Switching between A-rated anti-epileptic drug formulations does not increase seizure risk

Express Scripts, Inc., one of the largest pharmacy benefit management companies in North America, announced today results of a study that examined the association of seizure risk among epilepsy patients after switching between A-rated anti-epileptic drug formulations. The study found no evidence that switching between A-rated anti-epileptic drugs, including brand to generic substitution, was associated with increased emergency room visits or hospitalizations for epilepsy.

View full resource at news-medical.net

Tags: Emergency, Seizure, Epilepsy, Drug, Epilepsy Medication